======= TP53INP2 ======= == Gene Information == * **Official Symbol**: TP53INP2 * **Official Name**: tumor protein p53 inducible nuclear protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=58476|58476]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IXH6|Q8IXH6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TP53INP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TP53INP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617549|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Dual regulator of transcription and autophagy. Positively regulates autophagy and is required for autophagosome formation and processing. May act as a scaffold protein that recruits MAP1LC3A, GABARAP and GABARAPL2 and brings them to the autophagosome membrane by interacting with VMP1 where, in cooperation with the BECN1-PI3-kinase class III complex, they trigger autophagosome development. Acts as a transcriptional activator of THRA. {ECO:0000269|PubMed:18030323, ECO:0000269|PubMed:19056683, ECO:0000269|PubMed:22470510}. No Pfam Domain information is available for this gene. |autophagosome assembly| |autophagosome organization| |autophagosome| |ubiquitin binding| |PML body| |negative regulation of cellular protein localization| |positive regulation of autophagy| |osteoblast differentiation| |vacuole organization| |macroautophagy| |tissue homeostasis| |cytoplasmic vesicle| |ossification| |autophagy| |process utilizing autophagic mechanism| |multicellular organismal homeostasis| |regulation of autophagy| |anatomical structure homeostasis| |positive regulation of cellular catabolic process| |positive regulation of catabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |regulation of cellular protein localization| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |organelle assembly| |regulation of cellular catabolic process| |cellular macromolecule catabolic process| |regulation of cellular localization| |regulation of catabolic process| |regulation of protein localization| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |positive regulation of RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.41| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15500 * **Expression level (log2 read counts)**: 4.43 {{:chemogenomics:nalm6 dist.png?nolink |}}